ethyl 7-methyl-3-(3-(3-sulfamoylphenyl)thioureido)pyrazolo[1,5-a]pyrimidine-6-carboxylate

ID: ALA4851544

PubChem CID: 164611692

Max Phase: Preclinical

Molecular Formula: C17H18N6O4S2

Molecular Weight: 434.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1cnc2c(NC(=S)Nc3cccc(S(N)(=O)=O)c3)cnn2c1C

Standard InChI:  InChI=1S/C17H18N6O4S2/c1-3-27-16(24)13-8-19-15-14(9-20-23(15)10(13)2)22-17(28)21-11-5-4-6-12(7-11)29(18,25)26/h4-9H,3H2,1-2H3,(H2,18,25,26)(H2,21,22,28)

Standard InChI Key:  ONRGSRZYJKDFNW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   32.6340   -3.7269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.8168   -3.7269    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   32.2254   -4.4346    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.2892   -4.9073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9945   -5.3117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6998   -4.9073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6998   -4.0901    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2870   -4.0862    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9945   -3.6774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8244   -2.8781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0116   -2.7929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6795   -3.5396    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5827   -5.3179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9945   -6.1289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2868   -6.5375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.7022   -6.5375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.7022   -7.3547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4099   -7.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3710   -2.2706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1704   -2.4403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7170   -1.8328    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.4231   -3.2174    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   30.5164   -2.0025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7670   -2.7806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5655   -2.9505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1131   -2.3426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8565   -1.5623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0585   -1.3962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2710   -4.3349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  8  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  9  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
  4 13  1  0
  5 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 10 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 25  2  1  0
  2 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4851544

    ---

Associated Targets(Human)

CA5A Tclin Carbonic anhydrase VA (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.50Molecular Weight (Monoisotopic): 434.0831AlogP: 1.67#Rotatable Bonds: 5
Polar Surface Area: 140.71Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 10.09CX Basic pKa: 0.61CX LogP: 1.85CX LogD: 1.85
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.40Np Likeness Score: -2.37

References

1. Gumus A, Bozdag M, Angeli A, Peat TS, Carta F, Supuran CT, Selleri S..  (2021)  Privileged scaffolds in medicinal chemistry: Studies on pyrazolo[1,5-a]pyrimidines on sulfonamide containing Carbonic Anhydrase inhibitors.,  49  [PMID:34371130] [10.1016/j.bmcl.2021.128309]

Source